1. Home
  2. KALA vs PPSI Comparison

KALA vs PPSI Comparison

Compare KALA & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • PPSI
  • Stock Information
  • Founded
  • KALA 2009
  • PPSI 2008
  • Country
  • KALA United States
  • PPSI United States
  • Employees
  • KALA N/A
  • PPSI N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • PPSI Electrical Products
  • Sector
  • KALA Health Care
  • PPSI Industrials
  • Exchange
  • KALA Nasdaq
  • PPSI Nasdaq
  • Market Cap
  • KALA 26.2M
  • PPSI 30.0M
  • IPO Year
  • KALA 2017
  • PPSI N/A
  • Fundamental
  • Price
  • KALA $5.70
  • PPSI $3.14
  • Analyst Decision
  • KALA Strong Buy
  • PPSI Strong Buy
  • Analyst Count
  • KALA 3
  • PPSI 1
  • Target Price
  • KALA $14.00
  • PPSI $12.00
  • AVG Volume (30 Days)
  • KALA 137.8K
  • PPSI 56.5K
  • Earning Date
  • KALA 08-05-2025
  • PPSI 09-09-2025
  • Dividend Yield
  • KALA N/A
  • PPSI 47.77%
  • EPS Growth
  • KALA N/A
  • PPSI N/A
  • EPS
  • KALA N/A
  • PPSI 2.84
  • Revenue
  • KALA N/A
  • PPSI $26,304,000.00
  • Revenue This Year
  • KALA N/A
  • PPSI $24.01
  • Revenue Next Year
  • KALA N/A
  • PPSI $19.25
  • P/E Ratio
  • KALA N/A
  • PPSI $1.09
  • Revenue Growth
  • KALA N/A
  • PPSI 439.46
  • 52 Week Low
  • KALA $2.92
  • PPSI $2.25
  • 52 Week High
  • KALA $11.20
  • PPSI $7.00
  • Technical
  • Relative Strength Index (RSI)
  • KALA 59.39
  • PPSI 74.55
  • Support Level
  • KALA $5.39
  • PPSI $2.65
  • Resistance Level
  • KALA $6.30
  • PPSI $2.82
  • Average True Range (ATR)
  • KALA 0.63
  • PPSI 0.12
  • MACD
  • KALA 0.03
  • PPSI 0.06
  • Stochastic Oscillator
  • KALA 56.00
  • PPSI 87.20

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

Share on Social Networks: